GRAMEGNA, ANDREA
GRAMEGNA, ANDREA
Dipartimento di Fisiopatologia Medico-Chirurgica e dei Trapianti
Nutritional outcomes in people with cystic fibrosis receiving elexacaftor/tezacaftor/ivacaftor: A 24-month real-world study
2025 G. Alicandro, L. Zazzeron, V. Visciola, A. Bulfamante, A. Biffi, F. Corti, A. Gramegna, F. Blasi, V. Daccò
Bronchiectasis and sinonasal diseases: a narrative review
2025 E. Simonetta, A. De Angelis, M.S. Silani, V. Polelli, M. Nigro, A. Stainer, F. Amati, A. Gramegna, F. Pirola, G. Mercante, F. Blasi, L. Malvezzi, S. Aliberti
Impact of long-term high-flow nasal therapy on mucus plugs in patients with bronchiectasis
2025 C. Crimi, S. Nolasco, R. Campisi, M. Nigro, P. Impellizzeri, A. Cortegiani, A. Noto, A. Gramegna, C. Vancheri, F. Blasi, N. Crimi, S. Aliberti, A. Carlucci
Impact of elexacaftor/tezacaftor/ivacaftor (ETI) on the prescription refill rate (PRR) for inhaled medications in people with CF: an Italian multicenter analysis
2025 A. Gramegna, G. Cimino, M. Cipolli, G. Gandini, M.A. Calderazzo, A. Profiti, F. Piedepalumbo, F. Blasi
Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials
2025 C. Keating, L.M. Yonker, F. Vermeulen, D. Prais, R.W. Linnemann, A. Trimble, T. Kotsimbos, J. Mermis, A.T. Braun, M. O'Carroll, S. Sutharsan, B. Ramsey, M.A. Mall, J.L. Taylor-Cousar, E.F. Mckone, E. Tullis, T. Floreth, P. Michelson, P.R. Sosnay, N. Nair, R. Zahigian, H. Martin, N. Ahluwalia, A. Lam, A. Horsley, S. Krick, K. Mccoy, C. Goss, D. Weiner, J. Billings, C. Ren, J. Atkinson, R. Linnemann, A. Trimble, C. Frederick, T. Liou, H. Escobar, J. Wang, A. Deschamps, D. Froh, J. Chmiel, M. Wurth, L. Yonker, M. Jain, S. Millard, J. Tolle, A. Filbrun, J. Taylor-Cousar, F. Ruiz, C. Brown, B. Quick, P. Brown, J. Kennedy, J. Ruddy, B. Shkolnik, K. Pancham, E. Dimango, S. Fiel, G. Mueller, F. Livingston, A. Braun, B. O'Sullivan, P. Dubin, C. Teneback, T. Kremer, J. Welter, J. Hoppe, R. Jain, F. Calimano, J. Johannes, C. Daines, D. Green, T. Keens, C. Trillo-Alvarez, H. Scher, J. Mermis, B. Morrissey, J. Wallace, C. Barrios, J. Callison, Z. Holliday, R. Klingsberg, O. Efrati, M. Cohen-Cymberknoh, D. Prais, P. Azevedo, E. Quintana-Gallego, J. Wong, P. Mondejar-Lopez, A. Lopez Neyra, A. Amorim, S. Sivam, O. Asensio De La Cruz, M. Waller, C. Forseen, C. Marion, A. Dittrich, J. Lysinger, B. Casserly, C. Luna, S. Brown, J. Singer, D. Schellhase, J. Roberts, C. King, C. Byrnes, F. Ringshausen, H. Hebestreit, M. Lorenz, R. Ruppel, P. Drevinek, S. Dillenhofer, M. Stahl, W. Gleiber, L. Homola, S. Naehrig, F. Stehling, S. Sutharsan, R. Fischer, K. Poplawska, C. Haworth, N. Simmonds, D. Urquhart, J. Duckers, M. Carroll, P. Barry, S. Doe, T. Hilliard, G. Macgregor, N. Patel, N. Withers, D. Peckham, M. Ledson, U. Koser, S. Gartner, E. Blitz Castro, A. Sole Jover, D. Cox, E. Mckone, B. Plant, M. Williamson, B. Elnazir, T. Barbosa, M. Cols Roig, L. Burr, D. Henderson, P. Middleton, T. Kotsimbos, I. De Monestrol, M. Gilljam, U. Lindberg, C. Schwarz, S. Bode, M. Epton, A. Halasz, I. Laki, M. O'Carroll, S. Krick, K. Mccoy, C. Goss, D. Weiner, C. Ren, J. Atkinson, R. Linnemann, A. Trimble, C. Fortner, C. Frederick, T. Liou, H. Escobar, J. Wang, D. Froh, J. Chmiel, M. Wurth, L. Bilodeau, A. Lapey, M. Jain, S. Millard, J. Tolle, K. Moffett, S. Jia, J. Taylor-Cousar, C. Brown, P. Brown, A. Uluer, J. Ruddy, E. Sears, K. Pancham, C. Keating, S. Fiel, G. Mueller, G. Omlor, A. Braun, N. Mehdi, M.G. Tupayachi Ortiz, C. Teneback, T. Kremer, B. Messore, J. Hoppe, R. Jain, A. Lambert, Z. Mukadam, F. Calimano, C. Daines, M. Egan, D. Green, T. Keens, A. Wilhelm, B. Morrissey, S. Reyes, D. Schaeffer, J. Wallace, J. Callison, R. Klingsberg, Z. Szepfalusi, R. Epaud, S. Leroy, R. Fischer Biner, A. Moeller, D. Salvatore, O. Efrati, M. Cohen-Cymberknoh, D. Prais, L. Johnson, J. Wong, S. Gohy, A. Gramegna, H. Olesen, A. Tissot, C. Marguet, S. Sivam, M. Desai, M. Waller, L. Owens, T. Kherani, C. Marion, J. Lysinger, D. Sands, E. Bakkeheim, E. Tullis, M. Chilvers, B. Quon, L. Lands, M. Parkins, F. Tremblay, A. Maitra, B. Casserly, H. Staples, O. Elidemir, E. Chatziagorou, P. Tirakitsoontorn, D. Grenet, S. Brown, B. Linnane, J.M. Nicholson, K. Manika, A. Tatopoulos, C. Byrnes, R. Ruppel, M. Stahl, T. Pressler, F. Stehling, S. Sutharsan, A. Bagheri-Potthoff, R. Fischer, C. Haworth, N. Simmonds, J. Duckers, J. Legg, A. Horsley, G. Macgregor, D. Peckham, T. Lee, V. Houdouin, S. Ramel, I. Fajac, I. Sermet-Gaudelus, L. Kamphuis, K. Van Der Ent, F. Vermeulen, R. Chiron, P. Reix, E. Van Braeckel, C. Knoop, E. Vanderhelst, I. Durieu, S. Bui, L. Weiss, O. Le Rouzic, R. Van Der Meer, J. Roukema, J. Altenburg, D. Cox, E. Mckone, B. Plant, M. Williamson, P. Robinson, C. Wainwright, L. Burr, D. Henderson, S. Mulrennan, B. Clements, P. Middleton, T. Kotsimbos, G. Taccetti, M. Cipolli, V. Dacco, B. Fabrizzi, C. Castellani, E. Eber, D. Appelt, M. Studnicka, I. De Monestrol, M. Gilljam, E. Sapiejka, H. Mazurek, U. Lindberg, M. Engan, A. Sauty, J. Mankikian, M. Epton, A. Halasz, I. Laki, M. O'Carroll
Limited impact of Elexacaftor/Tezacaftor/Ivacaftor on CPET outcomes in an Italian cohort of people with cystic fibrosis: reinforcing the essential role of exercise training
2025 M. Retucci, A. Gramegna, S. Gambazza, M. Santambrogio, G. Putti, A. Mariani, M.C. Russo, M. Vicenzi, V. Daccò, F. Blasi
Cystic Fibrosis
2025 S. Misuraca, A. Gramegna, F. Blasi
How do climate conditions and urbanisation impact nontuberculous mycobacterial infections? An Italian nationwide case–control study
2025 P. Faverio, L. Del Castello, M. Spotti, P. Rebora, E.C. Maggioni, R. Salerno, A. Perotto, F. Luppi, F.R. Bertuccio, S. Reale, V. Fornari, F. Gozzi, B. Granozzi, F.L. Dente, F. Mariotti, J. Simonetti, G. Gualano, N. Riccardi, M. Ferrarese, L.R. Codecasa, G. Sotgiu, A. Gori, A. Gramegna, M. Ori, E. Simonetta, F. Blasi, S. Aliberti
Respiratory Outcomes and Aspergillus Serology Following Elexacaftor/Tezacaftor/Ivacaftor Therapy in People with Cystic Fibrosis and a History of Aspergillus fumigatus Infection
2025 C. Lanfranchi, G. Alicandro, L. Cariani, B.S. Orena, A. Gramegna, C. Rizza, F. Blasi, V. Daccò
Awareness of respiratory syncytial virus and other respiratory disease vaccines among healthcare professionals and their patients in Italy: Insights from a literature review and a web-based survey
2025 C. Micheletto, G. Lorenzini, S. De Grazia, F. Di Marco, R. Di Matteo, P. Faverio, A. Gramegna, M. Vicentini, F. Blasi
Alternative splicing and residual function potentially expand the therapeutic landscape of the CFTRdele2ins182 variant
2025 C. Pastorino, L. Menta, E. Pesce, M. Lena, V. Tomati, V. Capurro, M. Di Duca, V. Terlizzi, A. Gramegna, F. Blasi, C. Castellani, S. Cappato, F. Zara, N. Pedemonte, R. Bocciardi
Guidance for chest-CT in children and adults with cystic fibrosis: A European perspective
2025 M. Fayon, K. Hill, M. Waldron, B. Messore, L. Riberi, M. Svedberg, E. Lammertyn, S. Fustik, A. Gramegna, M. Stahl, A. Kerpel-Fronius, M. Balbi, P. Ciet, G. Chassagnon, C. Ferrero, P. Burgel, S. Sutharsan, M. Opitz, E. Andrinopoulou, G. Dournes, M. Maher, J. Duckers, H. Tiddens, I. Sermet
Bronchiectasis in a patient with Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy: a case report
2024 M.S. Silani, E. Simonetta, A. Gramegna, A. De Angelis, F. Blasi, S. Aliberti
Monitoring of ECFS quality standards for the clinical management of adults with cystic fibrosis
2024 A. Gramegna, S. Aliberti, A. Amorim, F. Blasi, S. Bourke, P. Burgel, F. Diamantea, I. Durieu, L. Fila, R.M.G. Moreno, B. Messore, E. Pokojová, G. Taccetti, S. Verhulst, A.V. Dugac, S. Wege, A. Duff, K.W. Southern, C. Castellani
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders
2024 F. Amati, G. Leonardi, M. Contarini, L.C. Morlacchi, A. Stainer, G. Pizzamiglio, S. Aliberti, F. Blasi, A. Gramegna
Heterogeneity in response to Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis
2024 G. Alicandro, A. Gramegna, F. Bellino, S.C. Sciarrabba, C. Lanfranchi, M. Contarini, M. Retucci, V. Daccò, F. Blasi
Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease
2024 A. Gramegna, G. Alicandro, C. Premuda, F. Lucca, L. Pinali, M. Retucci, V. Vespro, M.C. Andrisani, G. Carraffiello, F. Amati, S. Volpi, S. Aliberti, M. Cipolli, F. Blasi
Diagnostic delay in bronchiectasis: an Italian perspective
2024 C. Chessari, E. Simonetta, F. Amati, M. Nigro, A. Stainer, G. Sotgiu, M. Puci, A. Gramegna, F. Blasi, L.C. Morlacchi, A.A.M.D. Buscemi, V. Conio, V. Sanci, A.G. Corsico, P. Faverio, W. Michalak, F. Luppi, C. Crimi, C. Vancheri, R. Campisi, M.R. Vulpi, G.E. Carpagnano, M. Cicchetti, K. Sekretna, N. Scichilone, S. Battaglia, S. Aliberti
Standards of care and educational gaps in adult cystic fibrosis units: a European Respiratory Society survey
2024 A. Felipe Montiel, A. Álvarez Fernández, M. Culebras Amigo, F. Blasi, A. Gramegna, S. Elborn, A. Horsley, S. Madge, D. Stolz, N. Tabin, C. Pannetier, E. Polverino
Lung Clearance Index Improves in People with Cystic Fibrosis not Achieving a Clinical Important Difference in Forced Expiratory Volume in One Second After Elexacaftor/Tezacaftor/Ivacaftor Therapy
2024 V. Daccò, A. Gramegna, C. Rosazza, A. Mariani, A. Biffi, C. Lanfranchi, L. Zazzeron, F. Bellante, F. Blasi, G. Alicandro